Please share your details and download the presentation of Aagami Inc.
Please wait...
Value Proposition
Deep Experience of overcoming business and socio-cultural differences of various countries
Extensive ‘C’ level network nurtured for 22+ years
Global Deal making skills, honed for decades
Partners having combined experience of 250+ years
Supplementing your bandwidth to save time, effort & cost
110+ clients , 200+ Assignments
110+
Clients
200+
Assignments
250+
Years Global Experience
500+
US$ 500+ MM X-Border deals and Investments
What We Do
We supplement your bandwidth and act as an extension of your team
Our strengths are yours to leverage for initiatives such as,
IN Licensing, OUT Licensing, and Co-Development Partnerships
M & A, Regulatory, and New Market Entry Strategy
Business Development, Supply Chain, and Distribution Strategy
We appreciate the Innovation that Universities and Research Institutes bring. Having worked and brought deals for several Tech Transfer Offices, we understand your needs.
We support commercialization of your Innovations by,
Realistic Evaluation of commercial potential
With our Access to Global Commercial Network including Investors’, reaching out to the right people
Leveraging our ability to speak “ The Investors’ language”
Highlighting the Commercial Perspective
‘Out of box’ thinking to widen market applications
Using our ability to talk multi-cultural, multi geographical “Business’ language”
Through our global experience in Business/ Market Research, and access to a large 'C' level network, we cater to your need of crucial insights for decision making (often needed in global/regional initiatives).
We empower you by delivering,
Competitive Landscape Assessments
Opportunities Identification Reports
Price Discovery Research Report
Analysis of Portfolio
IP and Regulatory Landscape
Financial Modeling, NPV valuations
Market Potential Reports
Services
In/Out Licensing
Partnership / Co-Development
Funding / Investment
Mergers & Acquisitions
Market Entry, Market Development Strategy
Finding the Right Partners
Success Stories
Help us understand your needs
We are eager to contribute to your Success, please let us know your needs for a preliminary evaluation at no cost.
New Win - An Illinois company developing innovative therapies for resuscitation from sudden cardiac arrest
We have a new Client - An Illinois company developing innovative therapies for resuscitation from sudden cardiac arrest has appointed Aagami to suppor...
“ We are pleased by Aagami Team’s good work, in a professional and gracious manner. We would be delighted to recommend your services to others ”
CEO of a Oregon, US based Biotech
“ The virtues of working with Aagami include the team’s attentiveness to us and to the potential partners, persistence in follow-up and most of all, integrity”
Founder and CEO of a California based Biopharma
“ While we think we understand business, terminology and customs change from Country to Country. Without having an intimate knowledge of these differences, a gap if you will, it is difficult if not impossible to transact equitable arrangements. Aagami is the bridge that crosses this gap. Importantly it does so openly and honestly”
Founder and CEO of a publicly Listed Australian Technology Development Company
“ We have worked with many Consultants in US and Canada, however, in our experience, none of them are worthy of even standing in Aagami’s Shadow. We are blessed to have Aagami on our side. ”
CEO of a Specialty Chemicals company based in North America
The service provided was excellent. Everything was handled in a thorough & professional manner. A large number of opportunities were identified, facilitated and progressed to a conclusion.
VP of a UK based Pharma
Aagami Team are Very Professional and Prompt in communication
Founder of a US Labware Consumables Company
Aagami laid out a pretty clear process and stuck to it, which is not often the case when engaging advisors for BD assignments. Also Aagami were very well connected. We had the opportunity to sign two deals via Aagami, which we had not anticipated.
Stephen Yoder, CEO, Pieris Pharmaceuticals
Honest and transparent communication. Dedicated approach, hard working
Martin Welschof, CEO, Opsona Therapeutics
"We were very satisfied with the outcome, and the final report, along with much additional data from subsequent trials conducted by our current licensees, now forms a part of our extensive Drug Master File at the FDA."
Edward T. Maggio, PhD, CEO of Aegis Therapeutics (Currently Consultant to Neurelis, who purchased Aegis at the end of November 2018)
"Professional and disciplined approach to execution of the project."